-
Staurosporine in Apoptosis and Metastasis Research
2026-09-25
Use Staurosporine to create a controlled kinase-inhibition and apoptosis challenge, then test whether surviving tumor cells show durable changes in motility or signaling. This workflow connects a well-established cell-stress tool with research on prometastatic states, while emphasizing the controls needed to separate acute toxicity from survivor biology.
-
EZ Cap EGFP mRNA for DC Reporter Workflows
2026-09-25
Use EZ Cap EGFP mRNA to separate reporter expression from antigen-specific immune function when optimizing dendritic-cell delivery. The reference study shows why maturation state, pulse conditions, viability, and expression should be evaluated together—not treated as interchangeable measures of success.
-
Cy3 NHS ester (non-sulfonated): Workflow Guide
2026-09-24
Cy3 NHS ester (non-sulfonated) labels accessible amino groups on proteins, peptides, and oligonucleotides for orange fluorescence detection. It is suited to workflows that can tolerate an organic co-solvent; it is water-insoluble and may not suit delicate proteins or aqueous-only labeling.
-
EZ Cap EGFP mRNA for Reporter Assays
2026-09-24
Use EZ Cap EGFP mRNA to evaluate mRNA delivery and transient expression with a fluorescent readout, while separating delivery performance from cell health and assay timing. A murine dendritic-cell electroporation study offers useful timing and dose-response benchmarks—but not a universal recipe for every cell type or delivery method.
-
Morning Training Improves Endurance Adaptation in Mice
2026-09-23
In a six-week mouse study, early-active-phase endurance training produced a larger improvement in performance than late-active-phase training, despite lower absolute training volumes. The findings suggest that training time can influence adaptation, while muscle glycogen and liver glycogen measurements did not explain the group differences in this experiment.
-
Iron-Driven Lipid Peroxidation in Sickle Cell AKI
2026-09-23
This pre-proof study identifies renal iron accumulation and lipid peroxidation as mechanistic links between rhabdomyolysis and acute kidney injury in homozygous sickle cell mice. Transcriptomic, biochemical, functional, and histological data show that ferrostatin-1, Deferiprone, and hydroxyurea reduce iron-associated oxidative injury, although the findings remain preclinical and largely prophylactic.
-
Protein A/G Magnetic Co-IP/IP Kit for Complexes
2026-09-22
The Protein A/G Magnetic Co-IP/IP Kit uses recombinant Protein A/G magnetic beads to capture antibody-bound mammalian protein complexes for co-immunoprecipitation, SDS-PAGE, and mass spectrometry. It provides a practical sample-processing workflow for protein-protein interaction analysis, while the cited Trichoderma study supplies a biological example in which interaction screening can guide follow-up validation.
-
Baicalin in Adult Visual Plasticity Research
2026-09-22
Baicalin provides a practical small-molecule entry point for testing adult ocular dominance plasticity, with a defined 10 mg/kg preclinical benchmark and orthogonal imaging and electrophysiology readouts. This guide connects cortical plasticity workflows with cancer research applications while emphasizing formulation control, mechanism-specific controls, and study limitations.
-
Polymyxin B: From Membrane Damage to Translation
2026-09-21
Polymyxin B sulfate offers translational researchers a dual lens: direct membrane-disruptive activity against resistant Gram-negative bacteria and measurable effects on innate immune signaling. This article connects that biology with resistance surveillance, dendritic-cell assays, and sepsis and bacteremia models to support more decision-ready research.
-
Canagliflozin (hemihydrate): Lab Guide
2026-09-21
Canagliflozin (hemihydrate), SKU C6434, is evaluated through five practical laboratory scenarios involving viability assays, stock preparation, interpretation, and supplier selection. The guide distinguishes SGLT2 biology from mTOR activity and provides evidence-based handling recommendations for glucose metabolism research.
-
GSK J4 HCl: JMJD3 Inhibition Workflows
2026-09-20
GSK J4 HCl is a cell-permeable JMJD3 inhibitor for connecting H3K27 chromatin changes with inflammatory and tumor phenotypes. This guide translates the hCG–EZH2–CXCL10 findings into practical assay design, dose-finding, validation, and troubleshooting strategies.
-
Drug-Sensitized Yeast for mTOR Discovery
2026-09-19
The 2025 GeroScience study develops a genetically drug-sensitized Saccharomyces cerevisiae platform for detecting TOR/mTOR inhibitors at substantially lower concentrations than conventional yeast assays. Its controls identify pathway-dependent activity while showing that canagliflozin and several other tested compounds produced no evidence of TOR inhibition in this model.
-
Praeruptorin A Applied Research Workflows
2026-09-18
Build reproducible workflows around Praeruptorin A for ferroptosis, inflammatory-barrier injury, cardiomyopathy research, and tumor-cell invasion. This guide emphasizes dose selection, orthogonal readouts, formulation control, and pathway-level troubleshooting rather than single-marker conclusions.
-
EGFP mRNA m1Ψ: Calibrating Electroporation
2026-09-18
EGFP mRNA m1Ψ can function as more than a fluorescence control. This article presents a state-aware framework for separating RNA delivery, cell stress, translation, and functional antigen presentation during electroporation studies.
-
In Situ TIL Therapy via mRNA-LNP Delivery
2026-09-17
The ACS Nano study introduces an in situ tumor-infiltrating lymphocyte strategy that uses intratumoral lipid nanoparticles to deliver mRNA encoding a membrane-anchored anti-CD3 single-chain variable fragment. By engineering both tumor-associated macrophages and tumor cells, the approach promotes local polyclonal CD8+ TIL expansion and tumor-cell engagement, including in combination with anti-PD-1 therapy.